Novozymes A/S Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 39 Fair Values set on narratives written by author
NSIS B Community Narratives
Bioenergy And Biosolutions Demand Will Support Earnings Despite Regulatory And Competitive Headwinds
Enzyme Biosolutions And Preventive Health Trends Will Drive Long-Term Expansion
Emerging Markets And Biofuels Will Support A Stronger Long Term Outlook
Enzyme Biosolutions And Preventive Health Trends Will Drive Long-Term Expansion
View narrativeBioenergy And Biosolutions Demand Will Support Earnings Despite Regulatory And Competitive Headwinds
View narrativeEmerging Markets And Biofuels Will Support A Stronger Long Term Outlook
View narrativeTrending Discussion
No trending discussion available.
Recently Updated Narratives
NSIS B: India Capacity Expansion Will Shape Long Term Upside Potential
NSIS B: Elevated Expectations Will Hinge On Successful MicroBioGen Integration
NSIS B: Consumer Health Probiotics Expansion Will Support Higher Multiple Potential
Snowflake Analysis
Solid track record with excellent balance sheet and pays a dividend.
Novozymes A/S Key Details
- 1.36
- 56.39%
- 14.70%
- 25.8%
About NSIS B
- Founded
- n/a
- Employees
- 11098
- CEO
- Website
View website
Novozymes A/S produces and sells industrial enzymes, functional proteins, and microorganisms in Denmark, rest of Europe, North America, the Asia Pacific, the Middle East, Africa, and Latin America. It provides biosolutions for the food and beverage industry, such as dairy, baking, beverage, meat, plant-based, functional, and other foods, as well as precision protein and early lie nutrition. The company also offers bioenergy solutions including biodiesel; biogas from agricultural and industrial residues and food waste; biomass; carbon capture; ethanol for liquefaction, saccharification, fermentation, and fiber conversion; and renewable diesel. In addition, it provides dishwashing, home cleaning, laundry, medical, and industrial and institutional cleaning services; gastrointestinal, immune, mental, women’s, children’s cardiometabolic, and oral human health solutions. Further, the company offers corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; silage, diary and beef cattle, poultry, swine, aquaculture solutions; pet care solutions; leather and textiles solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions; and distilling, oils and fats, sustainable plastic solutions. Additionally, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novozymes A/S is headquartered in Lyngby, Denmark.